Sentences with phrase «value portfolio ii»

The following portfolios are restricted to specific institutional accounts: US Large Cap Value Portfolio II, US Large Cap Value Portfolio III, Tax - Mgd.
Value Portfolio II, Intl..

Not exact matches

For example, the portfolio could conceivably i) have the majority of its value in cash and cash equivalents, ii) have the majority of its value in fixed income investments, or iii) have net short equity exposure, among other possibilities.
My Portfolio is — UTI Midcap fund, Axis Long term equity fund, Franklin Prima plus, DSP Micro cap, Reliance growth fund, ICICI value discovery, BSL MIP II Wealth 25 & Sundaram select midcap.
The fair value team takes into account the relevant factors and surrounding circumstances, which may include: (i) the nature and pricing history (if any) of the security; (ii) whether any dealer quotations for the security are available; (iii) possible valuation methodologies that could be used to determine the fair value of the security; (iv) the recommendation of a portfolio manager of the fund with respect to the valuation of the security; (v) whether the same or similar securities are held by other funds managed by the Adviser or other funds and the method used to price the security in those funds; (vi) the extent to which the fair value to be determined for the security will result from the use of data or formulae produced by independent third parties and (vii) the liquidity or illiquidity of the market for the security.
GFS also provides the Funds with accounting services, including: (i) daily computation of net asset value; (ii) maintenance of security ledgers and books and records as required by the 1940 Act; (iii) production of a Fund's listing of portfolio securities and general ledger reports; (iv) reconciliation of accounting records; (v) calculation of yield and total return for a Fund; (vi) maintenance of certain books and records described in Rule 31a - 1 under the 1940 Act, and reconciliation of account information and balances among the Funds» custodian and Adviser; and (vii) monitoring and evaluation of daily income and expense accruals, and sales and redemptions of shares of the Funds.
This doesn't mean I'm actively avoiding the region (with plenty of value still on offer, in terms of individual markets / stocks), it just means: i) my European stock picks are allocated elsewhere in my portfolio — Luxury Goods being an obvious candidate, with the industry predominantly headquartered in Europe (whereas in the US, one could argue Tiffany (TIF: US) may be the only genuine luxury goods company, in the more traditional sense), and ii) despite the Brexit vote, I still think Ireland (& maybe even the UK) remains the best proxy bet in & for Europe (as I argued in my last post).
Tags for this Online Resume: Biotechnology, Diagnostic, Pharmaceutical, Marketing, Oncology, Strategy, Brand Planning, Global Marketing, New Product Planning, Pricing, Market Research, Brand Leader, Commercial, Commercialization, Launch, Drug Development, Matrix, Cross Functional, Digital, KOL, Key Opinion Leader, Portfolio, Management, Brand Team, Agency, Diabetes, Cardiovascular, Commercial Strategy, Corporate Affairs, Communications, Hematology, Urology, Neuroscience, phase 2, phase 3, phase II, phase III, Powerpoint, Excel, Word, Part B, Part D, Seattle, Portland, San Francisco, Executive Director, Senior Director, Director, Vice President, Go - To - Market, Value Proposition, Go To Market, Launch Planning, Access, Reimbursement, Payer, Market Development, Market Assessment, Pipeline, In - Line, Brand Management, Coaching, Leadership, Marketing Strategies, Marketing Strategy, Strategic Planning, Autoimmune, Early Stage, Pre-Launch, Pre Launch, Regulatory, Operations, Marketing Plan, Business Plan, Business Development, Market Analysis, Segmentation, Targeting, Companion Diagnostic, Target Product Profile, Pre-Clinical, Competition, Positoning, Branding, Sales, Budget, Sales Management, Communication Plan, Publication Plan, Project Management, Genetic, Genomic, Lifecycle, Long Range, Device, Late Stage, Direct Report, Indirect Report, New Molecular Entities, Competitive, Biopharmaceutical, Medical Device, Non-Promotional, Tactical, Execution, IND, Revenue, Partner, Clinical, Consult, Analytical, Problem Solver, Global, International, Affordable Care Act, Lymphoma, Leukemia, Prostate, Breast, Cancer, OPDP, Promotional, Promotions, Brand, Healthcare, Distribution, Infrastructure, IMS, Priority Review, Experienced, Patient, Consumer
«Reaching the $ 1 billion mark in aggregate portfolio value, based on purchase price, is a key milestone for Griffin - American Healthcare REIT II,» said the REIT's President and CEO Danny Prosky in a statement.
The sale of the portfolio completed the disposition of the properties held by the Cabot Industrial Value Fund II, which was launched in 2005 with an initial allocation of $ 450 million in equity.
a b c d e f g h i j k l m n o p q r s t u v w x y z